Kåre Andersson Gotschalck

1.9k total citations
33 papers, 519 citations indexed

About

Kåre Andersson Gotschalck is a scholar working on Oncology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Kåre Andersson Gotschalck has authored 33 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 17 papers in Pathology and Forensic Medicine and 14 papers in Cancer Research. Recurrent topics in Kåre Andersson Gotschalck's work include Genetic factors in colorectal cancer (17 papers), Cancer Genomics and Diagnostics (14 papers) and Colorectal Cancer Screening and Detection (10 papers). Kåre Andersson Gotschalck is often cited by papers focused on Genetic factors in colorectal cancer (17 papers), Cancer Genomics and Diagnostics (14 papers) and Colorectal Cancer Screening and Detection (10 papers). Kåre Andersson Gotschalck collaborates with scholars based in Denmark, United States and Spain. Kåre Andersson Gotschalck's co-authors include Ole Thorlacius‐Ussing, Søren Laurberg, Claus L. Andersen, Lene Hjerrild Iversen, Mette Nørgaard, Jesper Nors, Rune Erichsen, Mads H. Rasmussen, Anders Husted Madsen and Henrik Krarup and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Kåre Andersson Gotschalck

32 papers receiving 514 citations

Peers

Kåre Andersson Gotschalck
David B. Zhen United States
Richard M. Goldberg United States
Taekyu Lim South Korea
David B. Zhen United States
Kåre Andersson Gotschalck
Citations per year, relative to Kåre Andersson Gotschalck Kåre Andersson Gotschalck (= 1×) peers David B. Zhen

Countries citing papers authored by Kåre Andersson Gotschalck

Since Specialization
Citations

This map shows the geographic impact of Kåre Andersson Gotschalck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kåre Andersson Gotschalck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kåre Andersson Gotschalck more than expected).

Fields of papers citing papers by Kåre Andersson Gotschalck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kåre Andersson Gotschalck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kåre Andersson Gotschalck. The network helps show where Kåre Andersson Gotschalck may publish in the future.

Co-authorship network of co-authors of Kåre Andersson Gotschalck

This figure shows the co-authorship network connecting the top 25 collaborators of Kåre Andersson Gotschalck. A scholar is included among the top collaborators of Kåre Andersson Gotschalck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kåre Andersson Gotschalck. Kåre Andersson Gotschalck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Henriksen, Tenna Vesterman, Christina Demuth, Amanda Frydendahl, et al.. (2025). Timing of ctDNA Analysis Aimed at Guiding Adjuvant Treatment in Colorectal Cancer. Clinical Cancer Research. 31(9). 1676–1685. 2 indexed citations
3.
Conrad, John A., Tenna Vesterman Henriksen, Jesper Nors, et al.. (2025). The role of renal and liver function in clinical ctDNA testing. PLoS ONE. 20(2). e0319194–e0319194. 1 indexed citations
5.
Gotschalck, Kåre Andersson, Peter Astrup Christensen, Henrik Krarup, et al.. (2024). Exploring D-Lactate as a Biomarker for Acute Intestinal Necrosis in 2958 Patients: A Prospective Cross-Sectional Study. Journal of Emergency Medicine. 66(5). e619–e631. 2 indexed citations
6.
Nors, Jesper, Kåre Andersson Gotschalck, Rune Erichsen, & Claus L. Andersen. (2024). Incidence of late recurrence and second primary cancers 5–10 years after non‐metastatic colorectal cancer. International Journal of Cancer. 154(11). 1890–1899. 3 indexed citations
7.
Nors, Jesper, Kåre Andersson Gotschalck, Rune Erichsen, & Claus L. Andersen. (2024). Risk of recurrence in early-onset versus late-onset non-metastatic colorectal cancer, 2004–2019: a nationwide cohort study. The Lancet Regional Health - Europe. 47. 101093–101093. 2 indexed citations
8.
Gotschalck, Kåre Andersson, Peter Astrup Christensen, Henrik Krarup, et al.. (2023). Exploring I-FABP, endothelin-1 and L-lactate as biomarkers of acute intestinal necrosis: a case-control study. Scandinavian Journal of Gastroenterology. 58(12). 1359–1365. 3 indexed citations
9.
Rasmussen, Mads H., Amanda Frydendahl, Iben Lyskjær, et al.. (2023). DREAMS: deep read-level error model for sequencing data applied to low-frequency variant calling and circulating tumor DNA detection. Genome biology. 24(1). 5 indexed citations
10.
Torp‐Pedersen, Christian, et al.. (2023). The effect of antithrombotic treatment on the fecal immunochemical test for colorectal cancer screening: a nationwide cross-sectional study. Endoscopy. 55(5). 444–455. 1 indexed citations
11.
Liggett, Jason L., Jakob Kleif, Morten Rasmussen, et al.. (2023). Novel blood-based biomarker candidates in screening for colorectal cancer.. Journal of Clinical Oncology. 41(4_suppl). 244–244. 1 indexed citations
12.
Henriksen, Tenna Vesterman, Christina Demuth, Amanda Frydendahl, et al.. (2023). Impact of Whole Genome Doubling on Detection of Circulating Tumor DNA in Colorectal Cancer. Cancers. 15(4). 1136–1136. 10 indexed citations
13.
Henriksen, Tenna Vesterman, Thomas Reinert, Mads H. Rasmussen, et al.. (2022). Comparing single‐target and multitarget approaches for postoperative circulating tumour DNA detection in stage II–III colorectal cancer patients. Molecular Oncology. 16(20). 3654–3665. 11 indexed citations
14.
Gotschalck, Kåre Andersson, et al.. (2021). Preoperative findings on non-specific CT in patients with primary acute intestinal ischemia: a case–control study. European Journal of Trauma and Emergency Surgery. 48(4). 3025–3032. 2 indexed citations
15.
Henriksen, Tenna Vesterman, N. Tarazona, Thomas Reinert, et al.. (2020). 420P Minimal residual disease detection and tracking tumour evolution using ctDNA in stage I-III colorectal cancer patients. Annals of Oncology. 31. S419–S420. 2 indexed citations
16.
Frydendahl, Amanda, Michael Knudsen, Maria Bach Laursen, et al.. (2019). Validation of computational determination of microsatellite status using whole exome sequencing data from colorectal cancer patients. BMC Cancer. 19(1). 971–971. 19 indexed citations
17.
Jensen, Sarah Østrup, Nadia Øgaard, Mai‐Britt W. Ørntoft, et al.. (2019). Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer—a clinical biomarker discovery and validation study. Clinical Epigenetics. 11(1). 158–158. 107 indexed citations
18.
Krarup, Henrik, Kåre Andersson Gotschalck, Martin Berg Johansen, et al.. (2016). Poster Abstracts. Colorectal Disease. 18(S1). 44–125. 3 indexed citations
19.
Gotschalck, Kåre Andersson, et al.. (2011). Lunchtime Posters. Colorectal Disease. 13(s6). 16–27. 1 indexed citations
20.
Gotschalck, Kåre Andersson, Mette Nørgaard, Ole Thorlacius‐Ussing, & Søren Laurberg. (2009). Immunosuppressive disorders and risk of anal squamous cell carcinoma: A nationwide cohort study in Denmark, 1978–2005. International Journal of Cancer. 127(3). 675–684. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026